local_hospital

Centrum Medyczne "Hipokrates" s.c. Elżbieta i Grzegorz Grześk

Address
ul. Fryderyka Chopina 11A/2, 85-092 Bydgoszcz, Poland

Cardiovascular Diseases

This research site in Bydgoszcz is actively involved in studies focused on cardiovascular diseases, especially acute myocardial infarction, heart failure, hypertension, atherosclerotic cardiovascular disease, and elevated Lp(a). The trials are designed to test new treatments and evaluate whether they can better prevent major heart-related events and improve outcomes for people at high cardiovascular risk.

  • Studies in acute myocardial infarction and recurrent event prevention
  • Research in chronic heart failure, including symptom control and hospitalization reduction
  • Trials in hypertension, established cardiovascular disease, and broader risk reduction
  • Work on elevated lipoprotein(a) and major cardiovascular event prevention

At Centrum Medyczne "Hipokrates" s.c. Elżbieta i Grzegorz Grześk, this area reflects a strong focus on improving prevention and treatment strategies for serious heart and vascular conditions.

Metabolic and Kidney-Related Research

Another key area of clinical research here covers nutritional and metabolic diseases, with attention to chronic kidney disease and obesity-related heart failure. These studies aim to assess whether new therapies can protect kidney function, improve cardiovascular outcomes, and support people living with complex metabolic and cardiorenal conditions.

  • Studies of chronic kidney disease and preservation of kidney function
  • Research in heart failure with preserved or mildly reduced ejection fraction combined with obesity
  • Trials evaluating treatment approaches that may reduce hospitalization and improve long-term health

This line of research highlights the site’s interest in conditions where kidney, metabolic, and cardiovascular health overlap.

Nervous System and Sleep Disorders

The site also takes part in research within nervous system diseases, including insomnia disorder. These trials are centered on improving sleep outcomes and understanding whether new therapies can offer better relief for patients with persistent sleep problems.

  • Studies on insomnia disorder and sleep quality
  • Evaluation of treatments intended to improve daily sleep patterns

This area adds a patient-centered dimension to the Centrum Medyczne Grześk research portfolio by addressing a common condition that affects overall well-being.

Musculoskeletal and Pediatric Inflammatory Disease Research

Clinical trials at the site also include musculoskeletal diseases, particularly polyarticular-course juvenile idiopathic arthritis. This research is aimed at assessing the safety and effectiveness of new treatment options for children and adolescents living with inflammatory joint disease.

  • Studies in polyarticular-course juvenile idiopathic arthritis
  • Research focused on treatment safety, tolerability, and symptom control
  • Pediatric studies seeking better long-term management of inflammatory arthritis

Together, these trials show a broad clinical research profile spanning heart disease, kidney health, sleep medicine, and pediatric rheumatology.

Site Overview

assignment
10
connected trials
corporate_fare
11
sponsors
science
8
IMPs

Activity Indicator

Last 6 months

3
Trials started
0% vs previous period.
3
Trials started 6–12 months ago
10
Total trials linked
Highly Active
trending_flatStable0%
1
2
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
8
Sponsors (total)
11
Active sponsors
9

Sponsor Network

Top 9 by active trials.

lock +8 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 628 other sites in Poland

description
Trial volume
10
Outperforms 78% of sites
public
Therapeutic diversity
4areas
Outperforms 79% of sites
groups
Sponsor diversity
11sponsors
Outperforms 84% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centrum Medyczne "Hipokrates" s.c. Elżbieta i Grzegorz Grześk

lock Showing 1 of 10 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A MULTICENTER, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE EFFECTS OF TASIMELTEON VS. PLACEBO IN TREATING PEDIATRIC INSOMNIAVanda Pharmaceuticals Inc., Vanda Pharmaceuticals Netherlands B.V.Phase IIIRecruitingFeb 2026

IMP list

lock Showing 1 of 8 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Bi 6905172Unknown2025-08-222025-08-28

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.